U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07060157) titled 'Comparative Efficacy of Resveratrol 1 % Gel and Trichloroacetic Acid 20% in Treatment of Melasma: A Split-face Study' on March 21.
Brief Summary: 1. To evaluate the efficacy and safety of topical resveratrol 1 % gel in treatment of melasma.
2. To compare between the efficacy of topical resveratrol 1 %gel versrs chemical peeling with TCA 20% in melasma.
Study Start Date: July 22
Study Type: INTERVENTIONAL
Condition:
Melasma
Intervention:
DRUG: resveratrol 1 % gel
left side of face the patient will be given resveratrol 1 % gel once daily at night (Home use ).
DRUG: TCA20%
left side of face the patient will be given resveratr...